Welcome to Dr. Hamid Sanatinia's Virtual Headquarters
Temazolamide

Home

Should we treat or not???
Performace Status
Antiemetics
Growth Factors
Calculations
Chemo Precautions
TOXICITY CRITERIA
Antidepressants
Chemoprotection
MESNA
Dexrazoxane
Radioprotectants
Hypercalcemia of malignancy
Mucositis
Neutropenic Fever
Palliative Care
Radiation Oncology
<<<<<<<<<>>>>>>>>>
ALL
AML
Anal
Bladder Cancer
Brain Cancer
Breast (risk category)
Breast (adjuvant)
Breast (metastatic)
Breast (Xeloda)
Breast (hormonal)
Breast Cancer Genetics
Carcinoid
CLL
CML
COLON CANCER
Endometrial
Esophagous
Gastric
Gestational Trophoblastic Disease
Germ Cell (Ovary)
Hairy Cell Leukemia
Head/Neck
Head/Neck: ChemoRT abstracts
Head/Neck: Larynx
Head/Neck:Nasopharyngeal
Hodgkins
Islet Cell Tumors
Kidney
Liver
LUNG, NSC
Stage III Unresectable NSC Lung Cancer
Lung, SC
Lymphoma, Aggressive
Lymphoma, AIDS
Lymphoma, Burkitts
Lymphoma, CNS
Lymphoma, Cutaneous
Lymphoma, Indolent
Lymphoma, MALT
Lymphoma, Mantle cell
Lymphoma, Mediastinal B-Cell
Lymphoma, Refractory NHL
Melanoma
Mesothelioma
Multiple Myeloma
MDS
NHL
Ovarian
Pancreas
Prostate
Prostate (Hormonal)
Rectal Cancer
Sarcoma
Sarcoma, Ewing's
Sarcoma, Osteogenic
Skeletal Metastasis
Testicular Cancer
Thymoma
Thyroid Cancer
Waldenstrom's
Unknown Primary
<<<<<<<<<>>>>>>>>>
Molecular Genetics
Oncogenes, the list!
Immunoperoxidase stains
Tumor Markers
Bleomycin
Cisplatin
Etoposide
Ifosfamide
Methotrexate
Temazolamide
Mechanism of Action
Dose Modifications (Renal)
Dose Modifications (hepatic)
MDR

Temodar (Temazolamide)

Oral alkylating agent

Starting dose: 150 mg/m2/day for 5 days on a 28-day cycle.
Next cycle: Adjust dose according to nadir neutrophil & platelet counts in the previous cycle & at the start of each cycle.
Nadir usually occurs around day 22
Patients take temodar for a maximum of 2 years, or until disease progression or intolerable side effects occur.
______________________________________________________________

Dose modification:
Based on lowest counts at either Day 22 or Day 29:
1. ANC<1,000 or PLT<50,000 -‡ postpone therapy until ANC>1500 & PLT<100,000. Reduce dose by 50 mg/m2/d for subsequent cycle.
2. ANC 1000-1500 or PLT 50000-100000 -‡ Postpone therapy until ANC>1500 & PLT<100,000. Maintain initial dose.
3. . ANC>1,500 or PLT>100,000 -‡ Increase dose to or maintain dose at 200 mg/m2 X 5 days for subsequent cycle.
______________________________________________________________

Side Effects
Myelosuppression
Nausea & vomiting – mild to moderate
Fatigue – mild to moderate
Constipation, Headache, Diarrhea